Annual Meeting

Blending clinical, research perspectives to define early lipid disease

Courtney Chandler
Dec. 1, 2019

Rotonya Carr had little research experience before she began her medical residency fellowship at the University of Pennsylvania 11 years ago. After four years in med school and another four as a primary care physician, Carr joined the university’s gastroenterology specialization program, which includes emphasis on the liver.

Carr was interested in metabolism and endocrinology, so she elected to work in the lab of Rexford Ahima, who since has moved to Johns Hopkins University. Ahima was starting to focus on diseases related to fatty livers, and Carr dove right in.

“It was the best decision I made in my career,” Carr said. “I learned how to do bench science and learned about fatty liver disease from a clinical perspective and from a basic biology perspective too.”

The Journal of Lipid Research junior associate editors will present their work at the 2021 annual meeting, 2:15–3:30 p.m., Thursday, April 29.

Find out about registering for the annual meeting here.

Now an assistant professor in the UPenn department of medicine’s division of gastroenterology, Carr has made fatty liver disease her career. As a testament to her contributions to the field of lipid biology, she recently was selected as a junior editor for the Journal of Lipid Research.

Fatty liver disease, or FLD, is defined by the presence of fat in more than 5% of liver cells. Carr researches the early stages of FLD and wants to understand how dysregulation of lipid metabolism in the liver promotes disease. As a practicing clinician, she works with patients who have the disease she studies.

“My patients have so many questions related to the biology of their disease,” she said. “I can explain what’s going on in their bodies, and once they understand this connection between biology and disease, we see better results with their treatment plans.”

Mentorship at the bench is important to Carr; she takes pride in supporting trainees who, like her, may have started with limited lab experience. Her top two pieces of advice are useful for researchers and clinicians alike.

“Have passion about your area of work and surround yourself with supportive colleagues,” she said. “Your success will depend on you and your drive.”

Understanding lipid crosstalk in fatty liver disease

Rotonya CarrRotonya CarrFatty liver disease, or FLD, is the most common liver disease in the U.S. and is estimated to affect more than 30% of the population. The liver, the body’s largest internal organ, has myriad important roles, including converting food to fuel and processing fat. FLD can have alcohol-related and non-alcohol-related origins.

While the disease often is hard to diagnose in the early stages, this is exactly where Rotonya Carr has focused her research. Carr and colleagues have found that crosstalk between lipid droplets, which are lipid-rich cellular organelles, and lipid metabolism in the liver may relate to the development of FLD. She has identified a specific lipid droplet protein called perilipin 2 as a potential therapeutic target in alcoholic FLD and has related it to sphingolipid metabolism. Her lab is one of the only ones to identify ceramides, a specific family of lipid molecules, in lipid droplets.

Carr’s talk at the American Society for Biochemistry and Molecular Biology annual meeting will focus on the crosstalk among sphingolipid metabolism, lipid droplets and cellular components and how it relates to FLD.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Mapping proteins, one side chain at a time
Award

Mapping proteins, one side chain at a time

Jan. 7, 2026

Roland Dunbrack Jr. will receive the ASBMB DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

2026 voter guide
Society News

2026 voter guide

Jan. 6, 2026

Learn about the candidates running for Treasurer-elect, Councilor and Nominating Committee.

Meet the editor-in-chief of ASBMB’s new journal, IBMB
Profile

Meet the editor-in-chief of ASBMB’s new journal, IBMB

Jan. 5, 2026

Benjamin Garcia will head ASBMB’s new journal, Insights in Biochemistry and Molecular Biology, which will launch in early 2026.

Exploring the link between lipids and longevity
Profile

Exploring the link between lipids and longevity

Jan. 2, 2026

Meng Wang will present her work on metabolism and aging at the ASBMB Annual Meeting, March 7-10, just outside of Washington, D.C.

Defining a ‘crucial gatekeeper’ of lipid metabolism
Award

Defining a ‘crucial gatekeeper’ of lipid metabolism

Dec. 31, 2025

George Carman receives the Herbert Tabor Research Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Nuñez receives Vallee Scholar Award
Member News

Nuñez receives Vallee Scholar Award

Dec. 29, 2025

He will receive $400,000 to support his research.